Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Charles River Labs Pays $27 Million for China Lab Animals Provider

publication date: Oct 30, 2012
Charles River Labs, the global CRO, will pay $27 million to acquire a 75% stake in Vital River, the largest supplier of laboratory animals in China. Charles River has the right to acquire the remaining 25% at a future date. As its name implies, Vital River has had a very close relationship with Charles River. For the past 10 years, it has been a licensee for production and distribution of Charles River’s disease models in China. More details....

Stock Symbol: (NYSE: CRL)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital